Vaccinia virus (VACV) intracellular enveloped virus (IEV) particles are transported to the cell periphery on microtubules where they fuse with the plasma membrane to form cell-associated enveloped virus (CEV). Two IEV-specific proteins, F12L and A36R, are implicated in mediating transport of IEV. Without F12L, virus morphogenesis halts after formation of IEV, and CEV is not formed, whereas without A36R, IEV was reported not to be transported, yet CEV was formed, To address the roles of A36R and F12L in IEV transport, viruses with deletions of either F12L (vDF12L) or A36R (vDA36R) were labelled with enhanced green fluorescent protein (EGFP) fused to the core protein A5L, and used to follow CEV production with time. Without F12L, CEV production was inhibited by >99 %, whereas without A36R, CEV were produced at~60 % of wild-type levels at 24 h post-infection. Depolymerization of microtubules, but not actin, inhibited CEV formation in vDA36R-infected cells. Moreover, vDA36R IEV labelled with EGFP fused to the B5R protein co-localized with microtubules, showing that the A36R protein is not required for the interaction of IEV with microtubules. Time-lapse confocal microscopy confirmed that both wild-type and vDA36R IEV moved in a stop-start manner at speeds consistent with microtubular movement, although the mean length of vDA36R IEV movement was shorter. These data demonstrate that VACV IEV is transported to the cell surface using microtubules in the absence of A36R, and therefore IEV must attach to microtubule motors using at least one protein other than A36R.
INTRODUCTION
Vaccinia virus (VACV) replicates in perinuclear cytoplasmic regions termed virus factories (Dales & Siminovitch, 1961; Moss, 2001) . Four distinct infectious forms are produced. The first is called intracellular mature virus (IMV), which represents the majority of infectious progeny, but remains intracellular until cell lysis and is not sufficient for efficient cell-to-cell spread. A proportion of IMV is transported on microtubules from the factory, and is wrapped by two further membranes derived from the trans-Golgi network (Ichihashi et al., 1971; Hiller & Weber, 1985; Schmelz et al., 1994) or endosomal cisternae (Tooze et al., 1993; van Eijl et al., 2002; Ward, 2005) to form intracellular enveloped virus (IEV). IEV is transported to the cell surface in a microtubule-dependent manner that is reversibly inhibited by nocodazole (Geada et al., 2001; Hollinshead et al., 2001; Rietdorf et al., 2001; Ward & Moss, 2001b) , where it fuses with the plasma membrane to form cell-associated enveloped virus (CEV). Actin is polymerized beneath the CEV, which drives virions into neighbouring cells. A CEV that detaches from the cell can mediate long-range spread, and is termed an extracellular enveloped virus (EEV). For a review on the roles of the different virions in the virus life cycle, see Smith et al. (2002) .
Two VACV proteins, F12L (Zhang et al., 2000; van Eijl et al., 2002) and A36R (van Eijl et al., 2000) , are associated with IEV, but not IMV, CEV or EEV, and each has been implicated in IEV transport. Viruses lacking either protein form a small plaque and are highly attenuated in vivo (Parkinson & Smith, 1994; Zhang et al., 2000) . F12L is a 65-70 kDa protein that is conserved in chordopoxviruses (Zhang et al., 2000) . Confocal and electron microscopy has shown that, in the absence of F12L, VACV morphogenesis halts after the formation of IEV particles, and these are not transported to the cell periphery (van Eijl et al., 2002) . Although the role of F12L in IEV egress is unknown, its requirement for IEV transport makes it a prime candidate for direct or indirect interactions with microtubules (van Eijl et al., 2002) . A36R is a 45 kDa protein (Parkinson & Smith, 1994) with type 1b membrane topology, and with a 195 aa cytosolic domain that is located beneath CEV on the cytosolic face of the plasma membrane (Röttger et al., 1999; van Eijl et al., 2000) . Deletion of A36R does not prevent IEV and CEV production, but inhibits actin tail formation from the cell surface (Sanderson et al., 1998; Wolffe et al., 1998; Röttger et al., 1999; van Eijl et al., 2000) . An interaction between the cytoplasmic domain of A36R and the N-terminal tetratricopeptide repeat region of the microtubule motor kinesin was demonstrated using the yeast two-hybrid system, and GST (glutathione S-transferase) pull-down assays (Ward & Moss, 2004) . This implies an additional function of A36R in the recruitment of kinesin to IEV. However, CEV is still produced in viruses lacking this gene (Wolffe et al., 1998; Sanderson et al., 2000; van Eijl et al., 2000; Hollinshead et al., 2001) . Two previous reports concluded that IEV lacking A36R exhibited little (Ward & Moss, 2001a) or no (Rietdorf et al., 2001 ) movement.
Recombinant VACVs were described, in which the enhanced green fluorescent protein (EGFP) was fused to VACV core protein A5L (Carter et al., 2003) , and the IEV proteins F13L (Ward & Moss, 2000; Geada et al., 2001; Husain & Moss, 2001; Rietdorf et al., 2001 ) and B5R (Hollinshead et al., 2001; Ward & Moss, 2001b; . These viruses have been used to follow the movement of viral cores and whole virions in cells. To investigate the egress of VACV IEV, viruses lacking A36R or F12L (Parkinson & Smith, 1994; Zhang et al., 2000) were each labelled with EGFP on A5L to make vDA36R-EGFPA5L and vDF12L-EGFPA5L, respectively. In addition, vDA36R was labelled with EGFP fused to B5R (vDA36R-EGFPB5R) to investigate IEV localization and movement by confocal, and time-lapse fluorescent microscopy. Data presented here show that IEV lacking the A36R protein co-localize with microtubules, move at speeds consistent with microtubule transport and this movement is inhibited reversibly by microtubuledepolymerizing drugs. Therefore, IEV must attach to microtubule motors using at least one virally encoded protein other than A36R, and IEV are transported on microtubules without A36R.
METHODS
Cells. CV-1 cells were grown in minimum essential medium (MEM) (Invitrogen) supplemented with 10 % heat-inactivated fetal bovine serum (FBS) (Invitrogen). D980R and BS-C-1 cells were grown in Dulbecco's modified Eagles's medium (DMEM) (Invitrogen) with 10 % FBS. Ptk 2 cells (European Collection of Cell Cultures no. 88031601) were grown in low-glucose DMEM (Gibco) with 10 % FBS. Virus infections were performed with 2?5 % FBS for all cell types.
Recombinant virus construction. VACV strain Western Reserve (WR) and recombinant viruses derived from WR were used. VACV vDA36R (Parkinson & Smith, 1994) , vDF12L (Zhang et al., 2000) , vEGFPB5R and vEGFPA5L (Carter et al., 2003) were described previously. Recombinant VACV vDA36R-EGFPA5L, vDF12L-EGFPA5L and vDA36R-EGFPB5R were constructed by transient dominant selection (Falkner & Moss, 1990 ) using the Escherichia coli guanine xanthine phosphoribosyltransferase (Ecogpt)-encoding gene as the transiently selectable marker. CV-1 cells were infected with vDA36R or vDF12L at 0?05 p.f.u. per cell, and transfected 4 h later with pEGFPA5L (Carter et al., 2003) or pEGFPB5R in the presence of Lipofectin (Gibco-BRL), following the manufacturer's recommendations. Recombinant virus expressing Ecogpt was selected by three rounds of plaque purification in the presence of mycophenolic acid. The mycophenolic-acidresistant virus was then plaque purified once on D98R cells in the presence of 6-thioguanine (Sigma) to select against virus expressing the Ecogpt gene, followed by four rounds of plaque purification on BS-C-1 cells to isolate a pure population of virus. Ecogpt-negative virus containing either EGFPA5L or EGFPB5R was identified by PCR, and stocks were prepared and titrated by plaque assay on BS-C-1 cells.
Genome analysis by PCR. Genomes of VACV containing the EGFPA5L gene were analysed by PCR using oligonucleotide primers that either flanked the A5L gene (1, A5LFlankF 59-CTCCGTTGAATT-CGATGACTATAGGACAAGAACCCTCCTC-39 and 2, A5LFlankR 59-CGTACTCCAAGCTTGTGTAGATGCTACTTCGTCGATGG-39), amplified the EGFP gene (3, EGFPF 59-GTGAGCAAGGGCGAG-39 and 4, EGFPR 59-CTTGTACAGCTC-39), or amplified EGFPA5L only (oligonucleotides 3 and 2). These reactions produced DNA fragments of 2?3, 0?7 and 2?0 kb, respectively (see Supplementary  Fig . S1a available in JGV Online) for vDA36R-EGFPA5L and vDF12L-EGFPA5L viruses, confirming that the EGFPA5L gene had been inserted into the A5L locus.
The genome of vDA36R-EGFPB5R was analysed by PCR using oligonucleotide primers that either flanked the B5R gene (5, B5RFlankF 59-TCATTTAAGCTTCCTTCTTTCGTGAAATGC-39 and 6, B5RFlankR 59-GTACTCAAGCTTGCTTACAGAAACATCGCGTT-39), amplified the short consensus repeat (SCR) domains 2-4 of B5R (7, SCR2-4F 59-TGTGCACAGTTTCTGATTACAT-39 and 8, SCR2-4R 59-TCGTACACATATTGGGAGTAC-39), or amplified EGFPB5R only (oligonucleotides 3 and 6). These reactions gave DNA fragments of 1?7 and 1?6 kb using primers 5 and 6, and 3 and 6, respectively, but no product was obtained using primers 7 and 8 for the SCR 2-4 domains, confirming that the EGFPB5R gene had been inserted into the B5R locus, and that no wild-type B5R remained (see Supplementary  Fig . S1b available in JGV Online).
Confocal microscopy. To measure the formation of CEV, Ptk 2 cells were seeded onto 22 mm glass coverslips, grown to 50 % confluence, infected with vEGFPA5L, vDA36R-EGFPA5L or vDF12L-EGFPA5L at 1 p.f.u. per cell, and incubated for 0, 6, 8, 10 or 24 h at 37 uC. For the time-zero sample, the virus inoculum was added for 30 min on ice before processing for immunostaining and fixation. Live cells were stained on their surface with anti-B5R rat mAb 19C2 (diluted 1 : 50) for 1 h at room temperature, and were then blocked and permeabilized with 0?1 % saponin (Sigma). For fixation, cells were washed with ice-cold PBS, incubated with 4 % and then 8 % paraformaldehyde in 250 mM HEPES (10 min on ice and 20 min at room temperature, respectively), and quenched with 50 mM ammonium chloride for 10 min at room temperature. Bound antibody was detected with donkey anti-rat TRITC (tetramethylrhodamine B isothiocyanate)-conjugated antibodies (Jackson Immunoresearch Laboratories) diluted 1 : 250.
To investigate the effect of microtubule depolymerization on CEV production, cells were infected with 1 p.f.u. vEGFPA5L or vDA36R-EGFPA5L per cell, and incubated for 1 h. Then 10 mg N 1 -isonicotinoyl-N 2 -3-methyl-4-chlorobenzoylhydrazine (IMCBH) ml
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(kindly provided by Riccardo Wittek, University of Lausanne, Lausanne, Switzerland) was added for 11 h. At 12 h post-infection (p.i.) IMCBH was washed away and replaced with medium containing either fresh IMCBH (10 mg ml 21 ), nocodazole (33 mM), colchicine (250 mM) or cytochalasin D (1 mM), and incubated for 90 min at 37 uC. At 12?5 h p.i., CEV were identified as above. To improve the accuracy of CEV quantification, images of 66?5 zoomed areas of the cell surface from the 663 magnified optical field were acquired for each cell, and the number of CEV in this area was counted.
To study the localization of vEGFPB5R and vDA36R-EGFPB5R virions, Ptk 2 cells were infected with 1 p.f.u. per cell for 12 h, and fixed and permeabilized as above. Mouse mAb B-5-1-2 (diluted 1 : 2000; Abcam) that detects a-tubulin was added for 1 h at room temperature, and bound antibodies were detected with donkey anti-mouse TRITCconjugated antibodies (diluted 1 : 250). All samples were mounted in Vectashield (Vectorlabs) containing DAPI (4,6-diamidino-2-phenylindole), and were analysed using a Zeiss 510 Meta or LSM5 Pascal confocal microscope.
Time-lapse microscopy. Ptk 2 cells were grown to 30-40 % confluence on 38 mm coverslips (PeCon), and were infected with 5 p.f.u. vEGFPB5R or vDA36R-EGFPB5R per cell for 10 h. The coverslips were then transferred to a microscope stage preheated to 37 uC and the cells were observed on a Zeiss 510 Meta confocal microscope using Zeiss time-lapse software. Images were acquired at 0?98 s intervals for 180-250 frames at 10-14 h p.i.
Statistical analysis. Student's t-test was used to test for the significance of the results (P<0?05, unless stated otherwise).
RESULTS
To study the location and movement of viruses lacking A36R or F12L, the parental viruses lacking these genes (vDA36R and vDF12L) were labelled with EGFP fused to the N terminus of the A5L core protein. Despite the A5L protein being essential for virus replication, it had been shown previously that a virus in which A5L was replaced with the EGFP-A5L chimera underwent normal morphogenesis and made plaques very similar to those of the wild-type virus (Carter et al., 2003) . The viruses were constructed by transient dominant selection (see Methods), and their genomes were analysed by PCR with primers specific for the A5L gene, the EGFP gene and regions flanking the A5L gene locus ( Supplementary Fig. S1a available in JGV Online). These analyses showed that the genome of each virus was as predicted.
Location of virions in WT, vDA36R-and vDF12L-infected cells
Previous reports had indicated that the location of virions in cells infected by viruses lacking A36R or F12L was qualitatively different (van Eijl et al., 2000 (van Eijl et al., , 2002 . This was reassessed in cells infected with viruses lacking these genes and expressing EGFP fused to A5L. Fig. 1 shows that at 10 h p.i. the distribution of virions in cells infected with these viruses differ. F12L-negative virions are not widely dispersed in the cell, whereas the A36R-negative virions are distributed throughout the cell similar to vEGFPA5L (Fig. 1) . To test whether CEV is formed in the absence of F12L or A36R, live cells were stained with anti-B5R mAb, and the B5R signal was merged with the direct fluorescence from EGFP ( Fig. 1  merged images) . Double-positive structures represent cellsurface virions, CEVs. These data show that without A36R, virions are transported to the cell periphery and CEVs are present on the cell surface, whereas without F12L, virions remain in the central region of the cell and are not widely dispersed. F12L-negative IEV also failed to disperse even at later time points (data not shown). This observation does not fit with previous reports that without A36R IEV particles show little or no movement within infected cells (Rietdorf et al., 2001; Ward & Moss, 2001a) .
Time-course of CEV formation in vDA36R-EGFPA5L and VEGFP-A5L infection
The production of CEV over time was investigated in vEGFPA5L, vDA36R-EGFPA5L and vDF12L-EGFPA5L infection. Live cells were stained on their surface with anti-B5R mAb, and punctate areas of staining that colocalized with an EGFP signal were counted as CEV (Fig. 2) . Images from 20 cells were acquired at the indicated times p.i. and the mean number of CEV was calculated. As reported previously (Zhang et al., 2000) , without F12L CEV, formation was reduced 10-fold. In contrast, at 6, 8, 10 and 24 h p.i. CEV was found on vDA36R-infected cells but this was reduced by 98, 65, 54 and 38 % at these times compared with vEGFPA5L (Fig. 2) . The value at 24 h p.i. was not significantly different from wild type (Student's t-test), although at earlier time points (8 and 10 h) these differences were significant. These observations confirm that loss of A36R did not prevent CEV formation (Sanderson et al., 1998; Wolffe et al., 1998; Hollinshead et al., 2001; van Eijl et al., 2000 van Eijl et al., , 2002 , but the number of CEV was reduced and there was a delay in their appearance. It is possible that other investigators observed little or no IEV movement with viruses lacking A36R because only a time point relatively early in infection was investigated.
CEV formation requires intact microtubules in vDA36R-EGFPA5L infection
An intact microtubule network is needed for CEV production during wild-type VACV strain WR infection (Hollinshead et al., 2001) ; however, the involvement of microtubules in CEV formation by vDA36R was not investigated and it was suggested that IEV made by this mutant might use other transport mechanism(s) to reach the cell surface and form CEV (Ward & Moss, 2004) . The possible requirement for microtubules by vDA36R was investigated using the microtubule-depolymerizing drug nocodazole (Storrie et al., 1998) . In the presence of nocodazole, CEV particles were not formed after infection with vDA36R-EGFPA5L ( Fig. 1 and 2 ) or vDA36R (van Eijl et al., 2002) . However, nocodazole inhibits movement of IMV from the virus factory to the site of wrapping to form IEV particles (Sanderson et al., 2000; Ward, 2005) , as well as IEV egress, and therefore its effect on CEV formation could be due to inhibition of IMV movement, IEV movement or movement of both types of virion. Therefore, to measure IEV preferentially we added IMCBH, which inhibits wrapping of IMV to form IEV (Payne & Kristenson, 1979) , and quantified CEV formation at different times after IMCBH washout in the presence of nocodazole, colchicine, cytochalasin D or no drug (Fig. 3) . Under these conditions, IMV particles that have already been transported to sites of wrapping during the IMCBH block will be wrapped following IMCBH washout, and then be available for transport to the cell surface. In the presence of nocodazole, additional IMV will not be transported to sites of wrapping, 3 . The effect of microtubule depolymerization with nocodazole or colchicine on CEV production in vEGFPA5L (WR, white bars) or vDA36R-EGFPA5L (vDA36R, black bars) infection. Ptk 2 cells were infected at 1 p.f.u. per cell and IMCBH was added 1 h p.i. At 11 h p.i., the medium was replaced with medium with or without cytochalasin D, nocodazole, colchicine or IMCBH, and CEV was quantified at 12?5 h p.i., as described in Methods. and so CEV formation will derive from IEV already transported but not wrapped prior to IMCBH washout, or IEV that becomes CEV by a microtubule-independent mechanism. When IMCBH was washed out in the absence of nocodazole, numerous CEV virions were apparent for viruses with (vEGFPA5L) or without (vDA36R-EGFPA5L) the A36R protein. However, CEV formation was inhibited if IMCBH is washed out in the presence of nocodazole, or to a lesser extent, colchicine (Fig. 3) . This shows that an intact microtubule network is needed for formation of CEV in both vEGFPA5L and vDA36R-EGFPA5L infections. As a control, destabilizing actin with cytochalasin D did not affect the appearance of CEV significantly (Fig. 3) .
IEV co-localize with microtubules without the A36R protein
To address more directly the location and movement of IEV in cells infected with viruses lacking A36R, another recombinant VACV was constructed. This virus had the B5R protein modified to replace the four short consensus repeats (SCR) that are typical of the members of the complement protein family with EGFP. Such a chimera had been inserted into VACV previously , and used to show that VACV IEV uses microtubles for transport to the cell surface (Hollinshead et al., 2001 ). The new virus termed vDA36R-EGFPB5R was constructed by transient dominant selection using vDA36R as the parent virus and plasmid pEGFPB5R (see Methods). vDA36R-EGFPB5R lacked A36R, but had the fluorescent tag on the IEV envelope rather than the core, so that all intracellular movement of virions would be due to movement of IEV and not IMV. The plaque phenotype of vDA36R-EGFPB5R was indistinguishable from the parent virus vDA36R, and genome analysis by PCR using primers that flanked the B5R gene, or amplified EGFPB5R or the SCR domains 2-4 of B5R, showed that the genome of the virus was as predicted ( Supplementary Fig. S1b available in JGV Online).
The relative locations of microtubules and IEV were examined in Ptk 2 cells infected with vDA36R-EGFPB5R and vEGFPB5R (Fig. 4) using confocal microscopy. Microtubules were stained with a mAb to a-tubulin, and IEV was identified by virtue of its EGFP fluorescence. When a-tubulin and EGFP images were merged, the vast majority of IEV virions from both virus infections were coincident with microtubules. To quantify the proportions of IEV coincident with a-tubulin for each virus, and to determine whether these proportions differed between the viruses, images from 10 cells for each virus were acquired as z sections (0?36 mm slices) and a 300 mm 2 area was analysed for each cell. Overall, 155/167 (94 %) and 157/159 (97 %) of IEV for vEGFPB5R-and vDA36R-EGFPB5R-infected cells, respectively, was coincident with a-tubulin. There was no statistically significant difference between the two viruses (P 0?17, t-test). A similar result was obtained using BS-C-1 cells (data not shown). These data show that IEV are associated with microtubules in the absence of A36R.
IEV are transported on microtubules without the A36R protein
To determine whether IEV from vDA36R-EGFPB5R moved at speeds consistent with movement on microtubules, Ptk 2 Fig. 4 . Co-localization of microtubules and IEV particles. Ptk 2 cells were infected with vB5REGFP (WR) or vDA36R-B5REGFP (vDA36R) at 1 p.f.u. per cell, and at 12 h p.i. cells were fixed and stained with a mAb against a-tubulin. In the top two panels, the positions of EGFP IEV are shown as a merged image with a-tubulin (bar, 10 mm). The bottom two panels are magnified regions from the vDA36R and WR images (bar, 5 mm).
cells were infected at 5 p.f.u. per cell with vEGFPB5R or vDA36R-EGFPB5R. IEV movement was characterized by time-lapse microscopy 10-14 h p.i., and 180-250 images were captured every 0?98 s for each cell analysed. As reported previously (Carter et al., 2003) , many of the virus particles exhibited little movement during the period analysed and these may represent virions that have already moved or not yet moved. However, several particles showed clear movement in infections with either virus, and tracks of representative particle movement are shown (Fig. 5 and see Supplementary Fig. S2 available at JGV Online). To characterize IEV movement, the tracks of 100 IEV particles were characterized for each virus. Particles were tracked if they moved continuously for five time points or more, and tracking was stopped if the particle stalled for over three frames or disappeared from the field of view. The duration of run in seconds, the mean speed over the whole run and maximal speed were measured for each particle (Fig. 6 ). The (Ward & Moss, 2001b) . A noticeable difference, however, was that the length of uninterrupted particle movement was significantly shorter for vDA36R-EGFPB5R IEV (8?15±0?38 s) compared with vEGFPB5R (12?42±0?52 s; P<0?0001, t-test).
Collectively, these observations demonstrate that A36R is not required for movement of IEV particles on microtubules; however, the movement is subtly different in the absence of the A36R protein, and uninterrupted movement of particles was for a significantly shorter distance.
DISCUSSION
A recent publication reported a direct interaction between the VACV A36R protein and the kinesin light chain (Ward & Moss, 2004) , and this observation, together with reports that IEV particles have little or no movement in the absence of the A36R protein (Rietdorf et al., 2001; Ward & Moss, 2001a) , suggested a requirement for A36R in microtubuledependent movement of IEV particles. However, there remained a discrepancy in that VACV lacking A36R still released enveloped virus (Parkinson & Smith, 1994) and produced CEV particles on the cell surface (Sanderson et al., 1998; Wolffe et al., 1998; van Eijl et al., 2000 van Eijl et al., , 2002 Hollinshead et al., 2001) . Four possible reasons were postulated for this: IMV may be enveloped close to the plasma membrane (Ward & Moss, 2004) , IMV may bud at the plasma membrane as described for the IHD-W strain of VACV (Tsutsui, 1983) and fowlpox virus (Boulanger et al., 2000) , IEV proteins other than A36R may interact with kinesin, and lastly, another form of intracellular transport might be used (Ward & Moss, 2004) . To investigate these possibilities we constructed recombinant VACV lacking the A36R protein, and in which EGFP was tagged to either the core protein A5L or the IEV-, CEV-and EEV-specific protein B5R. Analysis of the time at which CEVs were present on the cell surface was followed after infection with viruses that lacked A36R or F12L, and compared with wild type. Without F12L, CEV production was reduced by >99 % at all time points tested, whereas without A36R, 65 and 54 % fewer CEV were found than in the control at 8 and 10 h p.i., but by 24 h p.i. this difference was reduced to only 38 % and was not significantly different. Only at the earliest time measured (6 h) was the production of CEV reduced greatly (>90 %) compared to the control. These data show that vDA36R IEV egress was delayed compared to wild-type, but that the production of CEV did not require A36R.
The next question addressed was whether IEV egress in the absence of A36R required microtubules. It was found that CEV formation was inhibited by microtubule-depolymerizing drugs both in the presence and absence of the A36R protein. This indicated that microtubules are needed for IEV egress in the absence of the A36R protein.
The relative locations of microtubules and IEV were then examined using viruses with EGFP fused to B5R with or without A36R. IEV particles were visualized by virtue of their EGFP fluorescence, and microtubules were stained with anti-a-tubulin mAb. When the EGFP and a-tubulin images were merged, the vast majority of IEV particles from both viruses were coincident with microtubules in all cells examined (Fig. 4) , providing evidence for co-localization of IEV particles and microtubules in the absence of A36R.
The movement of IEV made by viruses that did or did not express A36R (vEGFPB5R and vDA36R-EGFPB5R) was followed by time-lapse confocal microscopy from 10 to 14 h p.i. IEV from each virus were found to move at speeds consistent with movement on microtubules. However, the mean length of time of uninterrupted movement was significantly shorter for vDA36R-EGFPB5R IEV (Fig. 5) . Either this shorter movement, or the fact that CEV appearance was delayed without A36R, might explain why IEV movement was not found (Rietdorf et al., 2001) or appeared greatly restricted (Ward & Moss, 2001a) in earlier reports.
In summary, data are presented that show that the A36R protein is not required for transport of IEV to the cell surface, and that this transport is dependent on microtubules. This indicates that another protein(s) enables the interaction of IEV particles with microtubules. A candidate for this is the F12L protein, without which IEVs are not transported to the cell periphery and CEVs are not formed.
